FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc. to update or expand its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Viral Hepatitis

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

SUPPL AP for VIREAD (TENOFOVIR DISOPROXIL FUMARATE)